Litcius/Paper detail

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study

Guihong Wan, Wenxin Chen, Sara Khattab, Katie Roster, Nga Nguyen, Boshen Yan, Ahmad Rajeh, Jayhyun Seo, Hannah Rashdan, Leyre Zubiri, Matthew J. Hadfield, Shadmehr Demehri, Kun‐Hsing Yu, William Lotter, Alexander Gusev, Nicole R. LeBoeuf, Kerry L. Reynolds, Shawn G. Kwatra, Yevgeniy R. Semenov

2024The Lancet Oncology92 citationsDOIOpen Access PDF

Topics & Concepts

Adverse effectImmune systemMedicineImmunotherapyCohortRetrospective cohort studyImmunologyOncologyInternal medicineCancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisMultiple and Secondary Primary Cancers
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study | Litcius